CM Shinde presents Ratan Tata with ‘Udyog Ratna’, calls him an institution

Maharashtra Chief Minister Eknath Shinde on Sunday hailed industrialist Ratan Tata, the first-ever recipient of the ‘Udyog Ratna’ award instituted by the state government, as an “institution”.
Shinde also said industries in Maharashtra are the main strength of the growth engine.
He was speaking at the Udyog Puraskar 2023 distribution ceremony here where he praised Ratan Tata.
The ‘Udyog Ratna’ award was presented to the 85-year-old chairman emeritus of Tata Sons by Shinde and Deputy CMs Devendra Fadnavis and Ajit Pawar at the industrialist’s home in south Mumbai on Saturday.
On Sunday, Adar Poonawalla of Serum Institute was honoured with the Udyog Mitra award while the Udyogini award was given to Gauri Kirloskar. The best Marathi businessman award was bestowed upon Vilas Shinde, the MD of Sahyadri Farmers’ Producers Company.
None of us have seen God, but it is believed that God is everywhere. We have selected a ‘dev manoos’ (Godly person) like Ratan Tata for the (first ever) Udyog Ratna award. Tata means trust and quality assurance, and the company has always demonstrated its social connect, the chief minister said.
Industries in Maharashtra are the main strength of the growth engine. The state has thus decided to acknowledge the contribution of the industries through such awards, Shinde said.
The chief minister said he signed investment agreements worth Rs 1.37 lakh crore during his visit to Davos last year.
“Out of them, 85 per cent of agreements have progressed further. Maharashtra has once again topped the chart of attracting FDI (Foreign Direct Investments), he claimed.
Shinde said all industries, traders, businessmen and various chambers of commerce should form a high-power committee to prepare a blueprint for the next 25 years of the state’s progress.

Related Posts

  • Pharma
  • July 26, 2024
  • 118 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 108 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD